|
|
||||||||
Divisions of Nuclear Medicine and Orthopedic Surgery, National Cancer Center Hospital, Tokyo, Japan
Adviser for Bone Tumor Pathology in the Committee of Musculoskeletal Tumor, Japanese Orthopaedic Association, Tokyo, Japan
Correspondence: For correspondence contact: Shoji Terui, MD, Division of Nuclear Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan.
Correspondence: For reprints contact: Katsuyiki Ohtomo, MD, Department of Orthopedic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
ABSTRACT
Imaging results in patients with high-grade osteosarcoma of the extremities were reviewed to determine whether scintigraphic appearance correlated with histologic response to preoperative chemotherapy. Methods: Histologically, the percent tumor necrosis in specimens from 30 patients were classified into three grades: grade 1 = necrosis less than 60%, grade 2 = 6089%necrosis and grade 3 = diffuse necrosis greater than 90% based upon whole transverse sections. Scintigraphically, we analyzed 201Tl uptake before and after preoperative chemotherapy. The changes in the tumor-to-background ratio were defined by an alteration ratio. Results: Of the 11 patients with a grade 1 response, the ratio showed 67.1 % ± 45.4% (mean ± s.d.). Of the 9 patients with a grade 2 response, the ratio showed 37.9% ± 29.9% of the 10 patients with a grade 3 response the ratio showed 105.5% ± 12.4%. The ratios correlated well with the histologic grades (p < 0.0001; analysis of variance). Conclusion: Thallium-201 scintigraphy accurately assesses the effect of chemotherapy on osteosarcoma.
Key Words: thallium-201-chloride osteosarcoma preoperative the chemotherapy
This article has been cited by other articles:
![]() |
F. C. Eilber, G. Rosen, J. Eckardt, C. Forscher, S. D. Nelson, M. Selch, F. Dorey, and F. R. Eilber Treatment-Induced Pathologic Necrosis: A Predictor of Local Recurrence and Survival in Patients Receiving Neoadjuvant Therapy for High-Grade Extremity Soft Tissue Sarcomas J. Clin. Oncol., July 1, 2001; 19(13): 3203 - 3209. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |